Oncternal Therapeutics Inc. buy HC Wainwright
Start price
27.12.23
/
50%
€0.54
Target price
27.12.24
€1.81
Performance (%)
-41.48%
Price
05.01.24
€0.32
Summary
This prediction is currently active. The BUY prediction by HC_Wainwright for Oncternal Therapeutics Inc. is performing very badly with a performance of -41.48%. This prediction currently runs until 27.12.24. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Oncternal Therapeutics Inc. | - | - |
iShares Core DAX® | -1.471% | 1.895% |
iShares Nasdaq 100 | -0.486% | 4.395% |
iShares Nikkei 225® | -2.115% | 2.450% |
iShares S&P 500 | 0.394% | 3.118% |
Comments by HC_Wainwright for this prediction
In the thread Oncternal Therapeutics Inc. diskutieren
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $2.00 price target on the stock.
Ratings data for ONCT provided by MarketBeat
Stopped prediction by HC_Wainwright for Oncternal Therapeutics Inc.
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.32
12.08.24
12.08.24
€16.48
12.08.25
12.08.25
-
05.01.24
05.01.24
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.32
31.05.24
31.05.24
€17.46
31.05.25
31.05.25
-
05.01.24
05.01.24
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.32
13.05.24
13.05.24
€17.59
13.05.25
13.05.25
-
05.01.24
05.01.24
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.32
15.04.24
15.04.24
€26.28
15.04.25
15.04.25
-
05.01.24
05.01.24
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.32
29.01.24
29.01.24
€27.72
29.01.25
29.01.25
-
05.01.24
05.01.24